Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 1 hour 12 min ago

Myriad Publishes Clinical Utility Study for Prolaris(R)

Mon, 03/03/2014 - 13:37
Myriad Submits Updated Dossier for Medicare Reimbursement SALT LAKE CITY, March 3, 2014 -- (Healthcare Sales & Marketing Network) -- Myriad Genetics, Inc. (MYGN) today announced that it has published data from the PROCEDE 500 study in the journal Curren...
Diagnostics, Urology
Myriad Genetics, Prolaris test, prostate cancer

U.S. FDA Approves Bydureon(R) Pen (exenatide extended-release for injectable suspension) for Once-Weekly Treatment of Adults with Type 2 Diabetes

Mon, 03/03/2014 - 13:30
WILMINGTON, Del.--(Healthcare Sales & Marketing Network)--AstraZeneca (AZN) today announced that the U.S. Food and Drug Administration (FDA) has approved the Bydureon® Pen (exenatide extended-release for injectable suspension) 2 mg as an adjunct to die...
Biopharmaceuticals, Drug Delivery, Endocrinology, FDA
AstraZeneca, Bydureon Pen, exenatide, diabetes

Genentech Provides Update on Phase III Study of Onartuzumab in People with Specific Type of Lung Cancer

Mon, 03/03/2014 - 13:17
SOUTH SAN FRANCISCO, Calif.--(Healthcare Sales & Marketing Network)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that an independent data monitoring committee has recommended that the Phase III METLung study be stop...
Biopharmaceuticals, Oncology
Genentech, METLung study, onartuzumab, MetMab, NSCLC

Knight Therapeutics Inc. Appoints New CFO

Fri, 02/28/2014 - 16:14
MONTREAL, CANADA--(Healthcare Sales & Marketing Network) - Knight Therapeutics Inc. (TSX VENTURE:GUD) ("Knight") announced today that it has appointed Jeffrey Kadanoff as its Chief Financial Officer. Prior to joining Knight, Mr. Kadanoff was a Pr...
Biopharmaceuticals, Personnel
Knight Therapeutics

GW Pharmaceuticals Receives Orphan Drug Designation by FDA for Epidiolex(R) in the Treatment of Lennox-Gastaut Syndrome

Fri, 02/28/2014 - 13:16
LONDON, Feb. 28, 2014 -- (Healthcare Sales & Marketing Network) -- GW Pharmaceuticals plc (GWP.L) (GWPH) ("GW") announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for Epidiolex(R), GW's product ca...
Biopharmaceuticals, FDA
GW Pharmaceuticals, orphan drug designation, Epidiolex, Lennox-Gastaut

Abingworth Raises £225m ($375m) in its Tenth Life Sciences Fund

Fri, 02/28/2014 - 12:06
LONDON, February 28, 2014 -- (Healthcare Sales & Marketing Network) --Abingworth, the international investment group dedicated to life sciences and healthcare, today announced the final closing of its £225m ($375m) fund, Abingworth Bioventures VI (A...
Biopharmaceuticals, Devices, Venture Capital
Abingworth, Abingworth Bioventures, Avedro, eFFECTOR, GenSight Biologics

InterMune(R) Announces Support for First Ever European Patient Charter on Idiopathic Pulmonary Fibrosis (IPF)

Fri, 02/28/2014 - 11:58
MUTTENZ, Switzerland, February 28, 2014 -- (Healthcare Sales & Marketing Network) --To mark international Rare Disease Day, InterMune today announces its support for the development of a European Patient Charter for people with idiopathic pulmonary fibros...
InterMune, idiopathic pulmonary fibrosis

Beltone Launches Beltone First, a Revolutionary Hearing Aid

Thu, 02/27/2014 - 19:47
New Made-for-iPhone® Hearing Aid Offers a Whole New Hearing Experience CHICAGO--(Healthcare Sales & Marketing Network)--Beltone First™ hits the market today as a revolutionary hearing aid capable of streaming high-quality stereo sound from an iPhon...
Devices, Product Launch
Beltone, Beltone First, iPhone, hearing aid

Arno Therapeutics Appoints Lawrence A. Kenyon Chief Financial Officer

Thu, 02/27/2014 - 19:44
FLEMINGTON, N.J., Feb. 27, 2014 -- (Healthcare Sales & Marketing Network) -- Arno Therapeutics, Inc. (ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today announced that it has expanded its management...
Biopharmaceuticals, Oncology, Personnel
Arno Therapeutics, Onapristone

Integra LifeSciences Receives FDA Clearance for Integra(R) Titanium Bone Wedges

Thu, 02/27/2014 - 15:38
PLAINSBORO, N.J., Feb. 27, 2014 -- (Healthcare Sales & Marketing Network) -- Integra LifeSciences Holdings Corporation (IART) today announced the introduction of the Integra(R) Titanium Bone Wedges, designed for internal fixation for bone fractures or oste...
Devices, Orthopaedic, FDA, Product Launch
Integra LifeSciences, Titanium Bone Wedge, osteotomy

Oculus Innovative Sciences Announces Appointment of Russell Harrison to Board of Directors

Thu, 02/27/2014 - 15:35
PETALUMA, Calif., Feb. 27, 2014 -- (Healthcare Sales & Marketing Network) -- Oculus Innovative Sciences, Inc. (OCLS), today announced the appointment of Russell ("Russ") Harrison to its board of directors, effective February 26, 2014. "We...
Devices, Wound Care, Personnel
Oculus Innovative Sciences

Cardica Receives 510(k) Clearance For Both MicroCutter XCHANGE(TM) 30 White Cartridge And New Material

Thu, 02/27/2014 - 15:31
REDWOOD CITY, Calif., Feb. 27, 2014 -- (Healthcare Sales & Marketing Network) -- Cardica, Inc. (CRDC) today announced it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its MicroCutter XCHANGE™ 30 white cartridge for the sta...
Devices, Surgery, FDA
Cardica, MicroCutter, XCHANGE 30, surgical stapling

Covidien Completes Acquisition of Given Imaging

Thu, 02/27/2014 - 15:28
DUBLIN, Ireland--(Healthcare Sales & Marketing Network)--Covidien plc (COV) today announced that it has closed its acquisition of Given Imaging Ltd., providing the company additional scale and scope to serve a significant medical specialty, the multibillio...
Devices, Gastroenterology, Mergers & Acquisitions
Covidien, Given Imaging, PillCam, capsule endoscopy

Covidien Announces U.S. Food and Drug Administration 510(k) Clearance for the Puritan Bennett(TM) 980 Ventilator

Thu, 02/27/2014 - 15:25
New acute care ventilator delivers advanced breath technology for enhanced patient comfort and clinician ease of use DUBLIN, Ireland--(Healthcare Sales & Marketing Network)--Covidien plc (COV), a leading global provider of healthcare products and recogn...
Devices, FDA
Covidien, Puritan Bennett, ventilator

Quest Diagnostics Expands Hereditary Cancer Screening Offering with Lynch Syndrome Blood and Biopsy Testing for Colorectal Cancer

Wed, 02/26/2014 - 15:47
Company Supports March's Colorectal Cancer Awareness Month by Participating in the One Million Strong Screening Event in New York City on March 3 MADISON, N.J., Feb. 26, 2014 -- (Healthcare Sales & Marketing Network) -- Quest Diagnostics (DGX), the wor...
Diagnostics, Oncology, Product Launch
Quest Diagnostics, Lynch syndrome, hereditary nonpolyposis colorectal cancer

Nodality, Inc. Appoints Ralph Snyderman, M.D., to Board of Directors

Wed, 02/26/2014 - 15:21
SOUTH SAN FRANCISCO, Calif.--(Healthcare Sales & Marketing Network)--Nodality, Inc. announced today the appointment to the Company’s Board of Directors of Ralph Snyderman, M.D., Chancellor Emeritus at Duke University and James B. Duke Professor of Medicine...
Biopharmaceuticals, Personnel
Nodality, Single Cell Network Profiling, precision medicine

SafeOp Surgical Receives FDA Clearance for EPAD(TM) Neuromonitoring Device

Wed, 02/26/2014 - 12:16
GREENWICH, Conn.--(Healthcare Sales & Marketing Network)--SafeOp Surgical, Inc. (“SafeOp”) has received FDA clearance to market its Evoked Potential Assessment Device (EPAD™). The device is portable and intended for use in monitoring neurological status by...
Devices, Neurology, Monitoring, FDA
SafeOp Surgical, Evoked Potential, EPAD

Immunome Appoints New Management

Wed, 02/26/2014 - 12:12
Three Proven Industry Veterans Join the Strong Scientific Team Positions Immunome for Long Term Growth WYNNEWOOD, Pa.--(Healthcare Sales & Marketing Network)--Immunome, Inc., a biotechnology company with a unique and powerful immunotherapy discovery...
Biopharmaceuticals, Personnel
Immunome Inc

Mirvaso(R) (brimonidine) the First and Only Treatment Targeting the Facial Redness of Rosacea Approved by the European Commission

Wed, 02/26/2014 - 12:00
Galderma portfolio expands to offer a fast onset and long-acting alpha-2 adrenergic receptor agonist LAUSANNE, Switzerland, February 26, 2014 -- (Healthcare Sales & Marketing Network) --Galderma, a leading global pharmaceutical company exclusively focu...
Biopharmaceuticals, Dermatology, Regulatory
Galderma, Mirvaso, brimonidine, rosacea

Seno Medical Instruments Raising $39 Million in Series C Funding Round

Tue, 02/25/2014 - 16:04
Proceeds to support ongoing U.S. Pivotal Study of Imagio in the U.S. and activities to obtain CE Mark in E.U. SAN ANTONIO, Feb. 25, 2014 -- (Healthcare Sales & Marketing Network) -- Seno Medical Instruments, Inc., the company pioneering opto-acoustic i...
Devices, Diagnostics, Oncology, Venture Capital
Seno Medical Instruments, opto-acoustic imaging, Imagio breast imaging

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong